Top cited articles

Acceptance rate

21%

Time to first decision

12 days*

Impact Factor (JCR)

5.994

Impact Factor rank (JCR)

31/142

Citescore

9.0

Citescore rank

26/317

Risk of severe COVID-19 disease with ACE inhibitors and angiotensin receptor blockers: cohort study including 8.3 million people
Hippisley-Cox, Julia; Young, Duncan; Coupland, Carol et al
10.1136/heartjnl-2020-317393

Cardiovascular manifestations and treatment considerations in COVID-19
Kang, Yu; Chen, Tiffany; Mui, David et al
10.1136/heartjnl-2020-317056

Treatment with ACE inhibitors or ARBs and risk of severe/lethal COVID-19: a meta-analysis
Flacco, Maria Elena; Martellucci, Cecilia Acuti; Bravi, Francesca et al
10.1136/heartjnl-2020-317336

Colchicine for acute and chronic coronary syndromes
Imazio, Massimo; Andreis, Alessandro; Brucato, Antonio et al
10.1136/heartjnl-2020-317108

COVID-19 pandemic and troponin: indirect myocardial injury, myocardial inflammation or myocarditis?
Imazio, Massimo; Klingel, Karin; Kindermann, Ingrid et al
10.1136/heartjnl-2020-317186

Acute myocardial injury is common in patients with COVID-19 and impairs their prognosis
Wei, Jia-Fu; Huang, Fang-Yang; Xiong, Tian-Yuan et al
10.1136/heartjnl-2020-317007

Future risk of cardiovascular disease risk factors and events in women after a hypertensive disorder of pregnancy
Benschop, Laura; Duvekot, Johannes J.; van Lennep, Jeanine E. Roeters
10.1136/heartjnl-2018-313453

Impact of cardiovascular disease and cardiac injury on in-hospital mortality in patients with COVID-19: a systematic review and meta-analysis
Li, Xintao; Guan, Bo; Su, Tong et al
10.1136/heartjnl-2020-317062

Pulmonary hypertension and right ventricular involvement in hospitalised patients with COVID-19
Pagnesi, Matteo; Baldetti, Luca; Beneduce, Alessandro et al
10.1136/heartjnl-2020-317355

Left ventricular mechanical dispersion predicts arrhythmic risk in mitral valve prolapse
Ermakov, Simon; Gulhar, Radhika; Lim, Lisa et al
10.1136/heartjnl-2018-314269

Identification of novel pheno-groups in heart failure with preserved ejection fraction using machine learning
Hedman, Asa K.; Hage, Camilla; Sharma, Anil et al
10.1136/heartjnl-2019-315481

Long-term outcomes of His bundle pacing in patients with heart failure with left bundle branch block
Huang, Weijian; Su, Lan; Wu, Shengjie et al
10.1136/heartjnl-2018-313415

Impact of COVID-19 on percutaneous coronary intervention for ST-elevation myocardial infarction
Kwok, Chun Shing; Gale, Chris P.; Kinnaird, Tim et al
10.1136/heartjnl-2020-317650

Sub-optimal cholesterol response to initiation of statins and future risk of cardiovascular disease
Akyea, Ralph Kwame; Kai, Joe; Qureshi, Nadeem et al
10.1136/heartjnl-2018-314253

Diagnosis of patients with angina and non-obstructive coronary disease in the catheter laboratory
Rahman, Haseeb; Corcoran, David; Aetesam-ur-Rahman, Muhammad et al
10.1136/heartjnl-2019-315042

Cardiac transplantation: indications, eligibility and current outcomes
Bhagra, Sai Kiran; Pettit, Stephen; Parameshwar, Jayan
10.1136/heartjnl-2018-313103

Myocardial fibrosis: why image, how to image and clinical implications
Bing, Rong; Dweck, Marc Richard
10.1136/heartjnl-2019-315560

Effects and costs of real-time cardiac telerehabilitation: randomised controlled non-inferiority trial
Maddison, Ralph; Rawstorn, Jonathan Charles; Stewart, Ralph A. H. et al
10.1136/heartjnl-2018-313189

Prognosis and NT-proBNP in heart failure patients with preserved versus reduced ejection fraction
Salah, Khibar; Stienen, Susan; Pinto, Yigal M. et al
10.1136/heartjnl-2018-314173

Impact of body mass index on the outcome of catheter ablation of atrial fibrillation
Glover, Benedict M.; Hong, Kathryn L.; Dagres, Nikolaos et al
10.1136/heartjnl-2018-313490